BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coban A, Bilgin K, Tasdelen Fisgin N, Uzun M, Durupinar B. Effect of Meropenem against Multidrug-Resistant Mycobacterium tuberculosis. Journal of Chemotherapy 2013;20:395-6. [DOI: 10.1179/joc.2008.20.3.395] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Piccaro G, Poce G, Biava M, Giannoni F, Fattorini L. Activity of lipophilic and hydrophilic drugs against dormant and replicating Mycobacterium tuberculosis. J Antibiot (Tokyo) 2015;68:711-4. [PMID: 25944535 DOI: 10.1038/ja.2015.52] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
2 Davies Forsman L, Giske CG, Bruchfeld J, Schön T, Juréen P, Ängeby K. Meropenem-clavulanic acid has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 2015;59:3630-2. [PMID: 25824227 DOI: 10.1128/AAC.00171-15] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
3 Nzila A, Ma Z, Chibale K. Drug repositioning in the treatment of malaria and TB. Future Med Chem 2011;3:1413-26. [PMID: 21879845 DOI: 10.4155/fmc.11.95] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 6.2] [Reference Citation Analysis]